药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Pergolide
Tepoxalin
The risk or severity of adverse effects can be increased when Bosutinib is combined with Tepoxalin.
Pergolide
Fluprednisolone
The risk or severity of adverse effects can be increased when Bosutinib is combined with Fluprednisolone.
Pergolide
Antilymphocyte immunoglobulin (horse)
The risk or severity of adverse effects can be increased when Bosutinib is combined with Antilymphocyte immunoglobulin (horse).
Pergolide
Peginterferon beta-1a
The risk or severity of adverse effects can be increased when Bosutinib is combined with Peginterferon beta-1a.
Pergolide
Tixocortol
The risk or severity of adverse effects can be increased when Bosutinib is combined with Tixocortol.
Pergolide
Vilanterol
The risk or severity of adverse effects can be increased when Bosutinib is combined with Vilanterol.
Pergolide
Dinutuximab
The risk or severity of adverse effects can be increased when Bosutinib is combined with Dinutuximab.
Pergolide
Blinatumomab
The risk or severity of adverse effects can be increased when Bosutinib is combined with Blinatumomab.
Pergolide
Vedolizumab
The risk or severity of adverse effects can be increased when Bosutinib is combined with Vedolizumab.
Pergolide
Obinutuzumab
The risk or severity of adverse effects can be increased when Bosutinib is combined with Obinutuzumab.
Pergolide
Dimethyl fumarate
The risk or severity of adverse effects can be increased when Bosutinib is combined with Dimethyl fumarate.
Pergolide
Teriflunomide
The risk or severity of adverse effects can be increased when Bosutinib is combined with Teriflunomide.
Pergolide
Belimumab
The risk or severity of adverse effects can be increased when Bosutinib is combined with Belimumab.
Pergolide
Eribulin
The risk or severity of adverse effects can be increased when Bosutinib is combined with Eribulin.
Pergolide
Wortmannin
The risk or severity of adverse effects can be increased when Bosutinib is combined with Wortmannin.
Pergolide
Pralatrexate
The risk or severity of adverse effects can be increased when Bosutinib is combined with Pralatrexate.
Pergolide
Bendamustine
The risk or severity of adverse effects can be increased when Bosutinib is combined with Bendamustine.
Pergolide
Belatacept
The risk or severity of adverse effects can be increased when Bosutinib is combined with Belatacept.
Pergolide
Abetimus
The risk or severity of adverse effects can be increased when Bosutinib is combined with Abetimus.
Pergolide
Mepolizumab
The risk or severity of adverse effects can be increased when Mepolizumab is combined with Bosutinib.